Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size By Type (dPCR, qPCR), By Application (Clinical, Research), By Region, And Segment Forecasts, 2023 to 2032

The Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market was valued at USD 6.5 billion in 2023 and is projected to surpass USD 12.8 billion by 2031, registering a CAGR of 8.7% during the forecast period from 2023 to 2031.

The market's growth is primarily fueled by the rising prevalence of infectious diseases, increasing demand for precision medicine, and advancements in PCR technology. The expanding applications of dPCR and qPCR in clinical diagnostics, forensics, and environmental testing are further boosting market adoption. Additionally, the COVID-19 pandemic accelerated the use of PCR-based testing, reinforcing its necessity in healthcare and research laboratories worldwide.

Market Drivers

Growing Prevalence of Infectious Diseases and Genetic Disorders

The increasing burden of viral infections (e.g., COVID-19, HIV, HPV), genetic disorders, and cancer is driving the demand for highly accurate diagnostic tools such as dPCR and qPCR.

Technological Advancements in PCR

The emergence of automated, high-throughput PCR systems, multiplexing capabilities, and integration with artificial intelligence (AI) is improving efficiency and accuracy, fostering market expansion.

Increasing Demand for Precision Medicine & Molecular Diagnostics

PCR-based techniques are increasingly used in personalized medicine, targeted therapies, and oncology diagnostics, driving further adoption in the healthcare industry.

Market Restraints

High Cost of PCR Equipment & Reagents

Advanced PCR instruments require significant capital investment, making affordability a challenge, particularly for low- and middle-income countries.

Stringent Regulatory Approvals

The need for strict regulatory compliance (FDA, EMA, and other health authorities) delays product approvals and increases operational complexity for market players.

Market Opportunity

Expansion of PCR in Non-Clinical Applications

Growing use of PCR in agriculture, food safety testing, and environmental monitoring presents lucrative opportunities for market players.

Emerging Markets & Government Initiatives

Rising government funding in developing regions (Asia-Pacific, Latin America, Middle East) for molecular diagnostics and research infrastructure development offers significant market potential.

Market Segmentation

Market by Technology Insights

Real-Time PCR (qPCR) held the largest market share in 2023, owing to its widespread application in disease diagnostics, quantification of gene expression, and pathogen detection.

Digital PCR (dPCR) is expected to witness the fastest growth due to its higher precision, sensitivity, and ability to detect rare mutations.

Market by Application Insights

Clinical Diagnostics dominated the market, with applications in infectious disease testing, oncology, and genetic disorder screening.

Research & Development segment is growing rapidly, driven by the increasing focus on genomics, biomarker discovery, and drug development.

Market by End-Use Insights

Hospitals & Diagnostic Laboratories accounted for the largest revenue share, given the rising adoption of PCR in routine diagnostics and patient monitoring.

Pharmaceutical & Biotechnology Companies are anticipated to expand their market share due to increasing PCR usage in drug discovery, quality control, and clinical trials.

Market by Regional Insights

North America led the market in 2023, accounting for over 40% of the global revenue share, driven by strong research infrastructure, high healthcare expenditure, and the presence of major market players.

Asia-Pacific is expected to witness the highest CAGR during the forecast period, supported by increasing government investments in molecular diagnostics, growing biotech sector, and improving healthcare infrastructure.

Europe holds a significant market share, supported by advancements in PCR technology, strong regulatory frameworks, and widespread adoption in clinical laboratories.

Competitive Scenario

Key players operating in the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market include:

Thermo Fisher Scientific Inc.

Bio-Rad Laboratories, Inc.

QIAGEN N.V.

F. Hoffmann-La Roche Ltd.

Agilent Technologies, Inc.

Merck KGaA

Takara Bio Inc.

Fluidigm Corporation

Becton, Dickinson and Company

Danaher Corporation (Cepheid)

These companies are actively engaging in product innovations, mergers & acquisitions, strategic collaborations, and geographical expansions to strengthen their market presence.

Key Market Developments

January 2024: Thermo Fisher Scientific launched an AI-powered qPCR platform for high-throughput genetic analysis.

October 2023: QIAGEN introduced a portable digital PCR system to enhance field-based testing capabilities.

July 2023: Bio-Rad Laboratories announced a strategic partnership with a biotech startup to develop multiplexed dPCR assays for oncology applications.

Scope of Work – Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

Report Metric Details

Market Size (2023) USD 6.5 billion

Projected Market Size (2031) USD 12.8 billion

CAGR (2023-2031) 8.7%

Key Market Segments By Technology (qPCR, dPCR), By Application (Clinical Diagnostics, Research, Industrial), By End-Use (Hospitals, Biotech Companies)

Largest Market Segment Real-Time PCR (qPCR)

Leading Region North America

Fastest Growing Region Asia-Pacific

Key Players Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories, Roche, Agilent Technologies

Market Drivers Rising Infectious Disease Cases, Advancements in PCR Technology, Increasing Demand for Molecular Diagnostics

Market Opportunities Expansion in Non-Clinical Applications, Government Initiatives for Research Development

FAQs: Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

What is the current market size of the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market?

The market was valued at USD 6.5 billion in 2023 and is projected to grow significantly by 2031.

What is the major growth driver of the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market?

The major growth driver is the rising prevalence of infectious diseases and genetic disorders, alongside advancements in PCR technologies.

Which is the largest region during the forecast period in the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market?

North America is expected to remain dominant due to its strong healthcare infrastructure, high adoption of PCR-based diagnostics, and continuous technological advancements.

Which segment accounted for the largest market share in the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market?

Real-Time PCR (qPCR) accounted for the largest market share due to its widespread application in clinical diagnostics, pathogen detection, and gene expression analysis.

Who are the key market players in the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market?

Major players include Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories, Roche, and Agilent Technologies, among others.

This report provides an in-depth and structured analysis of the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market, covering key trends, drivers, challenges, and growth opportunities. The insights will be valuable for industry stakeholders, investors, researchers, and policymakers in navigating the evolving molecular diagnostics landscape.